WA
GWPH

Winfield Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Winfield Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-219
Closed -$29K – 743
2017
Q4 		$29K Hold
219
– – 0.01% 251
2017
Q3 		$22K Hold
219
– – 0.01% 278
2017
Q2 		$22K Buy
+219
New +$23.6K 0.01% 280

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Winfield Associates's GWPH Position: Q1 2018 in Review

Winfield Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 219 shares — an estimated $29K sold.

Winfield Associates first reported a position in GWPH in Q2 2017 and held it in 3 quarters. The position peaked at $29K in Q4 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

  • Winfield Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 219 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $29K.
  • Winfield Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 3 quarters.
  • Winfield Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $29K in Q4 2017.
  • 191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.